Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Streets Hottest Drug Stocks Ahead of 2025
| TEVA Stock | USD 21.92 0.24 1.11% |
About 52% of Teva Pharma's investors are presently thinking to get in. The analysis of overall sentiment of trading Teva Pharma Industries stock suggests that some investors are interested at this time. The current market sentiment, together with Teva Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharma Industries stock news signals to limit their universe of possible portfolio assets.
Teva |
Duquesne Family Offices chief is cashing in his chips on two leading artificial intelligence stocks in favor of a drugmaker whose shares are up by 112 percent for the year.
Read at fool.com
 |
Teva Pharma Fundamental Analysis
We analyze Teva Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teva Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teva Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Teva Pharma is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Teva Pharma Industries Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
Peers
Teva Pharma Related Equities
| TLRY | Tilray | 1.69 | ||||
| CRON | Cronos | 1.02 | ||||
| LFCR | Lifecore Biomedical | 0.62 | ||||
| HLN | Haleon Plc | 0.54 | ||||
| ELAN | Elanco Animal | 0.08 | ||||
| VTRS | Viatris | 0.35 | ||||
| TAK | Takeda Pharmaceutical | 1.00 | ||||
| SNDL | SNDL | 1.11 | ||||
| ZTS | Zoetis | 2.05 | ||||
| BHC | Bausch Health | 2.75 | ||||
| ACB | Aurora Cannabis | 2.78 | ||||
| CGC | Canopy Growth | 3.11 | ||||
| SHPH | Shuttle Pharmaceuticals | 4.55 |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |